Comparative study of the effects of PACAP in young, aging, and castrated males in a rat model of Parkinson's disease

Annals of the New York Academy of Sciences

Volumn 1070, Issue , 2006, Pages 518-524

  Reglodi D ^a,c   Tamas A ^a   Lengvari I ^a   Toth, G ^b   Szalontay, L ^a   Lubics, A ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Age; Gender; Neuroprotection; PACAP; Parkinson

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; BEHAVIOR; CASTRATION; CELL LOSS; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENDOCRINE FUNCTION; MALE; NONHUMAN; PARKINSON DISEASE; RAT;

EID: 33746456340     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1317.072     Document Type: Conference Paper

References (16)

1. ARIMURA, A. 1998. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn. J. Physiol. 48: 301-331
2. WASCHEK, J.A. 2002. Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration Dev. Neurosci. 24: 14-23.
3. SOMOGYVARI-VIGH, A. & D. REGLODI. 2004. Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Rev. Curr. Pharm. Des. 10: 2861-2889.
4. TAKEI, N., Y. SKOGLOSA & D. LINDHOLM. 1998. Neurotrophic and neuroprotective effects of pituitary adenylate cyclase activating polypeptide (PACAP) on mesencephalic dopaminergic neurons. J. Neurosci. Res. 54: 698-706.
5. REGLODI, D., A. LUBICS, A. TAMAS, et al. 2004. Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease. Behav. Brain Res. 151: 303-312.
6. REGLODI, D., A. TAMAS, A. LUBICS, et al. 2004. Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats. Regul. Pept. 123: 85-94.
7. REGLODI, D., A. TAMÁS & A. SOMOGYVARI-VIGH. 2005. Pituitary adenylate cyclase activating polypeptide in animal models of neurodegenerative disorders - implications for Huntington and Parkinson's diseases. Lett. Drug Des. Discov. 2: 239-244
8. TAMAS, A., A. LUBICS, L. SZALONTAY, et al. 2005. Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine- induced lesion of the substantia nigra in rats. Behav. Brain Res. 158: 221-229.
9. COLLIER, T.J., C.E. SORTWELL & B.F. DALEY. 1999. Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: an argument for neurotrophic supplementation. J. Neurosci. 19: 5563-5573.
10. SCHWARTING, R.K. & J.P. HUSTON. 1996. The unilateral 6-hydroxydopamine lesion model in behavioral brain research: analysis of functional deficits, recovery and treatments. Prog. Neurobiol. 50: 275-331.
11. VAUDRY, D., C. ROUSSELLE, M. BASILLE, et al. 2002. PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis. Eur. J. Neurosci. 15: 1451-1460.
12. ITO, Y., M. ARAKAWA, K. ISHIGE, et al. 1999. Comparative study of survival signal withdrawal- and4-hydroxynonenal-induced cell death in cerebellar granule cells. Neurosci. Res. 35: 321-327.
13. DELGADO, M., J. LECETA & D. GANEA. 2003. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the production of inflammatory mediators by activated microglia. J. Leukoc. Biol. 73: 155-164.
14. M. DELGADO & D. GANEA. 2003. Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation. FASEB J. 17: 944-946.
15. MASUO, Y., J. NOGUCHI, S. MORITA, et al. 1995. Effects of intracerebroventricular administration of pituitary adenylate cyclase activating polypeptide (PACAP) on the motor activity and reserpine-induced hypothermia in murines. Brain Res. 700: 219-236.
16. LEE, F.S., R. RAJAGOPAL, A.H. KIM, et al. 2002. Activation of trk neurotrophin receptor signaling by pituitary adenylate cyclase activating polypeptides. J. Biol. Chem. 277: 9096-9102.